e-learning
resources
Vienna 2003
Tuesday 30.09.2003
Cell and molecular biology of pulmonary hypertension and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Permeabilized skeletal muscle fiber technique: a tool to unravel energy metabolism dysfunction in myopathy during chronic lung diseases
K. Guerrero, C. Pison, B. Wuyam, L. Kay, J. C. Borel, R. Hacini, B. Aguilaniu, P. Mezin, V. Saks (Grenoble, France)
Source:
Annual Congress 2003 - Cell and molecular biology of pulmonary hypertension and COPD
Session:
Cell and molecular biology of pulmonary hypertension and COPD
Session type:
Oral Presentation
Number:
2542
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Guerrero, C. Pison, B. Wuyam, L. Kay, J. C. Borel, R. Hacini, B. Aguilaniu, P. Mezin, V. Saks (Grenoble, France). Permeabilized skeletal muscle fiber technique: a tool to unravel energy metabolism dysfunction in myopathy during chronic lung diseases. Eur Respir J 2003; 22: Suppl. 45, 2542
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Comparison of different methods to screen skeletal muscle function in chronic wasting diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 22s
Year: 2001
Differential effects of emphysema on skeletal muscle fibre atrophy in hamsters
Source: Eur Respir J 2004; 23: 703-707
Year: 2004
The influence of comorbid factors on muscle function, morphology and metabolism in COPD
Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=99
Year: 2003
Mitochondrial functional alterations in COPD locomotor muscle are independent of cachexia and fiber type shift
Source: International Congress 2014 – Pathophysiological mechanisms at different scales
Year: 2014
Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 19: 617-625
Year: 2002
Skeletal muscle inflammatory markers in COPD patients with muscle wasting
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010
From muscle disuse to myopathy in COPD: potential contribution of oxidative stress
Source: Eur Respir J 2005; 26: 703-719
Year: 2005
Decreased muscle PPAR concentrations: a mechanism underlying skeletal muscle abnormalities in COPD?
Source: Eur Respir J 2007; 30: 191-193
Year: 2007
Skeletal muscle dysfunction and the related mechanism in chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Healthcare and treatment of COPD
Year: 2009
Impaired coordination of skeletal muscle protein turnover signalling in sarcopenic COPD patients
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016
Decreased expression of genes involved in skeletal muscle oxidative metabolism in COPD patients with muscle wasting
Source: Annual Congress 2008 - Respiratory muscle pathophysiology
Year: 2008
In vitro and in vivo contractile properties of the vastus lateralis muscle in males with COPD
Source: Eur Respir J 2003; 21: 273-278
Year: 2003
Muscle morphology, metabolism and muscle function: general principles
Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=86
Year: 2003
Uncoupling protein-3 content is decreased in peripheral skeletal muscle of patients with COPD
Source: Eur Respir J 2003; 22: 88-93
Year: 2003
Assessment of skeletal muscle fiber type distribution and morphometry in patients with COPD and chronic hypoxemia
Source: Eur Respir J 2003; 22: Suppl. 45, 538s
Year: 2003
Does oxidative stress modulate limb muscle atrophy in severe COPD patients?},
Source: Eur Respir J 2012; 40: 851-862
Year: 2012
Features of skeletal muscle dysfunction in COPD patients with obesity
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept